Friday 6 November 2026
Export COR’s income statement to Excel — free account
Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.
- Revenue
- +5.52%
- EPS
- +258.4%
- Free cash flow
- −7.81%
- Total debt
- +47.1%
Quarter to September 2026, against a year earlier
334.79
4.89
−1.44%
Follow COR
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
16.64 | 20.93 | 23.94 | 40.30 |
+8 more quarters Free account |
P/S ratio |
0.17 | 0.16 | 0.19 | 0.20 | |
P/FCF ratio |
14.76 | 13.31 | 38.15 | 17.97 | |
P/Operating CF |
18.47 | 20.59 | 45.65 | (28.46) | |
P/B ratio |
17.69 | 16.87 | 17.05 | 31.30 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.19 | 0.19 | 0.22 | 0.22 | |
EV/EBITDA |
15.49 | 15.46 | 18.58 | 19.22 | |
EV/Operating CF |
13.29 | 13.19 | 31.34 | 16.73 | |
EV/FCF |
16.41 | 15.48 | 44.52 | 19.66 | |
Quick Ratio |
0.50 | 0.48 | 0.48 | 0.47 | |
Current Ratio |
0.94 | 0.93 | 0.95 | 0.92 | |
Net Debt/EBITDA |
0.00 | 6.37 | 7.26 | 6.02 | |
Debt/Assets |
12.93% | 13.99% | 15.17% | 10.11% | |
Debt/Equity |
3.06 | 3.62 | 3.45 | 3.78 | |
Asset Turnover |
4.12 | 4.22 | 4.30 | 4.42 | |
Operating CF/Net income |
5.97 | 3.48 | 0.82 | (4.12) | |
Capex/Depreciation |
0.00 | (0.81) | (0.63) | (0.29) | |
Interest Coverage |
6.65 | 7.96 | 8.13 | 10.50 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.46% | 2.52% | 2.52% | 2.09% | |
Intangible Assets out of Total Assets |
0.26 | 0.27 | 0.28 | 0.22 | |
Share Based Compensation of Revenue |
0.00% | 0.03% | 0.04% | 0.08% | |
Graham Net Nets |
(0.44) | (0.46) | (0.41) | (0.34) | |
Graham Number |
0.00 | 71.42 | 73.75 | 45.11 | |
Earnings Yield |
6.01% | 4.78% | 4.18% | 2.48% | |
Free Cash Flow Yield |
6.77% | 7.51% | 2.62% | 5.56% | |
Revenue per Share |
463.01 | 438.81 | 402.77 | 442.45 | |
Operating CF per Share |
16.26 | 13.74 | 6.88 | (11.87) | |
Capex per Share |
(2.33) | (1.16) | (0.85) | (0.39) | |
Free Cash Flow per Share |
13.93 | 12.58 | 6.03 | (12.26) | |
Cash per Share |
25.57 | 14.58 | 11.19 | 9.03 | |
Shareholders Equity per Share |
19.29 | 16.77 | 18.43 | 10.79 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
19.29 | 16.77 | 18.43 | 10.79 | |
Free Cash Flow |
2,658.35 | 2,430.06 | 1,173.74 | (2,381.49) | |
Working Capital |
(3,929.33) | (3,861.96) | (2,991.38) | (4,980.57) | |
Capital Expenditures |
(444.28) | (224.00) | (164.90) | (76.32) | |
Net Current Asset Value |
(24,972.17) | (25,231.32) | (24,926.24) | (22,113.67) | |
EV/EBIT |
16.20 | 20.90 | 25.57 | 26.75 | |
Capex to Sales |
0.01 | 0.00 | 0.00 | 0.00 | |
Price to Operating Income |
14.58 | 17.97 | 21.91 | 24.45 | |
| Other line items | |||||
Average Receivables |
25,779.80 | 25,004.92 | 24,304.12 | 25,262.82 | |
Average Payables |
56,365.58 | 52,871.84 | 50,996.19 | 52,987.34 | |
Average Inventory |
20,927.99 | 20,584.10 | 19,487.76 | 22,293.26 | |
Average Assets |
81,847.55 | 78,881.23 | 76,422.99 | 73,707.76 | |
Average Common Equity |
— | 2,724.49 | 2,382.38 | 1,228.93 |
Columns are period end dates · fundamentals updated 5 Nov 2026